Scientific Sessions 2025  /  TCT at AHA: Heart Team in Action: Arrhythmogenic Mitral Valve Prolapse: Predicting Risk, Protecting Patients, and Personalizing Treatment  /  EP Assessment of Arrhythmias and SCD Risk
Logo

American Heart Association

  45
  0

Final ID:

EP Assessment of Arrhythmias and SCD Risk

  • Chugh, Sumeet  ( Cedars-Sinai Medical Center , Los Angeles , California , United States )
  • Albert, Christine  ( Cedars-Sinai Medical Center , Los Angeles , California , United States )
    • Author Disclosures:
    Sumeet Chugh: DO have relevant financial relationships ; Research Funding (PI or named investigator):National Heart Lung and Blood Institute:Past (completed) | Christine Albert: DO have relevant financial relationships ; Consultant:Bayor:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Medtronic:Active (exists now) ; Consultant:Element Science:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Heart Team in Action: Arrhythmogenic Mitral Valve Prolapse: Predicting Risk, Protecting Patients, and Personalizing Treatment

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Arrhythmogenic Mitral Valve Prolapse: Definition, Prevalence, Prognosis, and How to Predict
Sudden Death

Basso Cristina, Perazzolo Marra Martina, Enriquez-sarano Maurice, Michelena Hector

Current Strategies for Medical Treatment of Arrythmogenic Mitral Valve Prolapse

Tribouilloy Christophe, Enriquez-sarano Maurice, Michelena Hector

More abstracts from these authors:
Protecting first faculty appointments

Albert Christine

Common Genetic Variants Impacting Sudden Cardiac Death

Albert Christine, Chugh Sumeet, Arking Dan

You have to be authorized to contact abstract author. Please, Login
Not Available